KROS filings
Corporate insider profile
Lorena Raquel Lerner Filing Activity
Latest reported as Chief Scientific Officer of Keros Therapeutics, Inc. (KROS).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$36,714.72
- Latest transaction
- Aug 18, 2026
Affiliated corporations
Reported company relationships
Transaction history
